第16回がん専門医ダイレクトライブ「尿路上皮(膀胱)癌の早期発見のサインはこれだ！」」20250928

Value of the Information & Strength of the Argument

The video provides substantial value by delivering accurate, up-to-date information on bladder cancer early detection and treatment, directly from specialists. The argumentation is solid, grounded in clinical evidence and guidelines. The experts explain complex concepts (e.g., sensitivity vs. specificity) with clear examples, making the information accessible without oversimplifying. They also address common misconceptions, such as the significance of hematuria and the role of urine cytology. The discussion is balanced, acknowledging uncertainties and the need for individualized care. The inclusion of a cancer survivor adds a patient perspective, enhancing the practical relevance.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is high: the speakers are qualified specialists, and the content aligns with established medical knowledge. The video references the Japanese Society of Medical Oncology’s certified navigator program, but no specific scientific publications are cited. The title accurately reflects the content, focusing on early detection signs. The description includes a disclaimer about unapproved commercial tests, which is responsible. The video includes a brief sponsored segment (approximately 30 seconds) that is not endorsed by the society, but this does not affect the scientific content.

The title accurately reflects the content, which focuses on early detection signs of urothelial (bladder) cancer, as presented in the keynote lecture and subsequent Q&A.

8/10

The video features a board-certified urologist (Professor Fujita) and an oncologist (Professor Oki) from major Japanese universities, providing evidence-based information on bladder cancer. The discussion is grounded in established medical knowledge, including risk factors, diagnostic methods, and treatment options. The speakers clearly distinguish between evidence-based practices and unapproved commercial tests, and they emphasize the importance of proper clinical evaluation. The content is consistent with current medical guidelines, though it is primarily an expert opinion format rather than a systematic review.

• 00:00配信開始・挨拶
• 02:44特別ゲスト紹介：藤田和利先生（近畿大学）
• 03:40サバイバー紹介：サバカジさん（大腸がん・腎がんサバイバー）
• 06:06基調講演：尿路上皮（膀胱）癌の早期発見のサイン（藤田先生）
• 08:00膀胱がんの最大のリスクは「タバコ」
• 10:30最重要サイン：痛みのない赤い尿（無症候性肉眼的血尿）
• 12:20尿潜血陽性と指摘されたらどうすべきか
• 15:35膀胱がんの種類（筋層非浸潤性 vs 筋層浸潤性）
• 18:50膀胱温存を目指すBCG注入療法とその副作用
• 23:10膀胱全摘除術と尿路変成（回腸導管・新膀胱）の選び方
• 27:15最新の薬物療法：免疫チェックポイント阻害薬とADCの衝撃
• 32:41ディスカッション：血尿が出た時に「様子を見てしまう」怖さ
• 43:55第2部：事前質問回答コーナー
• 44:20Q1：腎盂・尿管がん術後の膀胱再発を防ぐことはできるか
• 50:15Q2：BCGが効かなくなった場合の次の治療選択肢
• 56:30Q3：ストマ（回腸導管）生活でのスポーツや入浴の実際
• 1:05:10Q4：高齢者における膀胱がん手術の適応と判断基準
• 1:12:35Q5：尿路上皮がんにおける遺伝子パネル検査の活用
• 1:25:20リアルタイムチャット回答：上皮内がん（CIS）の治療戦略など
• 1:45:00エンディング：血尿は「身体からの赤い信号」

• 認定がんナビ制度 (Certified Cancer Navigator Program) — Mentioned in the video description as a resource for certified cancer navigators.

• Bladder cancer - Mayo Clinic — Corroborates the information on symptoms, risk factors, and diagnosis of bladder cancer.

• www.youtube.com